There was a special ribbon cutting ceremony Thursday, which officially opened Las Cruces artist Kathy Morrow’s rock art display at the New Mexico State University ...

Heavy snow is expected in the northern mountains of New Mexico. Snow accumulations of 6 to 12 inches are possible in areas below 8,500 feet with 18 inches above 8,500 feet. Winds could gust as high as ...

Snow-covered area in March across the western United States was 8 percent below average, ranking seventeenth in the 25-year satellite record. Snow cover duration was just above the twenty-fifth ...

Calmer winds on the backside of Tuesday’s windy system that has brought in below-normal temperatures in place with mostly dry ...

New Mexico, the Land of Enchantment, offers so many wonderful experiences for families. They run the gamut from historical to ...

Innisfree McKinnon, University of Wisconsin-Stout (THE CONVERSATION) President Donald Trump’s executive order to rename the Gulf of Mexico and Alaska ... would use the new names in official documents, ...

SHANGHAI, March 21, 2025 /PRNewswire/ -- At the Appliance & Electronics World Expo (AWE 2025) opened on March 20 in Shanghai, Changhong unveiled a comprehensive suite of AI-driven home appliances.

On Friday, Elevation Oncology shares faced a significant ... The company’s focus will likely pivot to other assets in its pipeline or new strategic directions following this significant change ...

Friday, Elevation Oncology (NASDAQ:ELEV) experienced a change in stock rating as Citizens JMP analysts downgraded the company’s shares from Market Outperform to Market Perform. The decision came ...

SHANGHAI, March 21, 2025 /PRNewswire/ -- At the Appliance & Electronics World Expo (AWE 2025) opened on March 20 in Shanghai, Changhong unveiled a comprehensive suite of AI-driven home appliances.

Investing.com -- Shares of Elevation Oncology , Inc. (NASDAQ ... with plans to file an Investigational New Drug (IND) application in 2026. The company’s President and CEO, Joseph Ferra, expressed ...

Elevation Oncology (Nasdaq: ELEV) has decided to discontinue development of EO-3021, a Claudin 18.2 antibody-drug conjugate (ADC) which was being developed for the treatment of advanced, unresectable ...